Literature DB >> 20805441

Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors.

Edgar J Paredes-Gamero1, Valquíria P Medeiros, Eduardo H C Farias, Giselle Z Justo, Edvaldo S Trindade, Ana L Andrade-Lopes, Rosely O Godinho, Antonio de Miranda, Alice T Ferreira, Ivarne L S Tersariol, Helena B Nader.   

Abstract

Previous reports have shown that heparin may promote human hypotension and vascular relaxation by elevation of NO levels through unclear mechanisms. We hypothesized that endothelial muscarinic M(3) receptor activation mediates the heparin-induced vasodilation of rat aortic rings. The experiments were carried out using unfractionated heparin extracted from bovine intestinal mucosa, which elicited an endothelium and NO-dependent relaxation of aortic segments with maximal potency and efficacy (EC(50): 100±10 μmol/L; E(max): 41±3%). Atropine and 1,1-dimethyl-4-diphenylacetoxypiperidinium iodide inhibitors reduced the heparin-dependent relaxation, indicating that M(3) muscarinic receptor is involved in this phenomenon. However, no direct binding of heparin to muscarinic receptors was observed. More importantly, studies performed using the arginine-glycine-aspartic acid peptide and 1-(1,1-dimethylethyl)-3-(1-naphthalenyl)-1H-pyrazolo[3,4-day]pyrimidin-4-amine, an Src family inhibitor, reduced by 51% and 73% the heparin-dependent relaxation, respectively, suggesting the coupling of heparin and M(3) receptor through extracellular matrix molecules and integrin. Furthermore, unfractionated heparin induced activation of focal adhesion protein kinase, Src, and paxillin. Finally, fluorescence resonance energy transfer approach confirmed the interaction of the M(3) receptor to integrin. Taken together, these data demonstrate the participation of M(3) receptor and integrin in heparin-dependent relaxation of vascular smooth muscle. These results provide new insights into the molecular mechanism and potential pharmacological action of heparin in vascular physiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20805441     DOI: 10.1161/HYPERTENSIONAHA.110.156877

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy.

Authors:  Kesavan Suresh Babu; Jaymin Bhagwanji Morjaria
Journal:  Ther Adv Chronic Dis       Date:  2017-03-24       Impact factor: 5.091

2.  Sulodexide promotes arterial relaxation via endothelium-dependent nitric oxide-mediated pathway.

Authors:  Joseph D Raffetto; Fiorella Calanni; Paolo Mattana; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-04-20       Impact factor: 5.858

Review 3.  The function of SH2B3 (LNK) in the kidney.

Authors:  Gregory Blass; David L Mattson; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20

4.  Systolic blood pressure as a potential target of sigma-1 receptor agonist therapy.

Authors:  Jordana B Cohen; Michael L Perlis; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-15       Impact factor: 3.738

5.  Heparin inhibits angiotensin II-induced vasoconstriction on isolated mouse mesenteric resistance arteries through Rho-A- and PKA-dependent pathways.

Authors:  Hui Xie-Zukauskas; Jharna Das; Billie Lou Short; J Silvio Gutkind; Patricio E Ray
Journal:  Vascul Pharmacol       Date:  2012-12-23       Impact factor: 5.773

Review 6.  Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects.

Authors:  George Karakiulakis; Michael Roth
Journal:  Mediators Inflamm       Date:  2012-11-24       Impact factor: 4.711

7.  Post-translational allosteric activation of the P2X7 receptor through glycosaminoglycan chains of CD44 proteoglycans.

Authors:  Gedd Moura; S V Lucena; M A Lima; F D Nascimento; T F Gesteira; H B Nader; E J Paredes-Gamero; Ils Tersariol
Journal:  Cell Death Discov       Date:  2015-10-05

8.  Functional and molecular evidence for heteromeric association of P2Y1 receptor with P2Y2 and P2Y4 receptors in mouse granulocytes.

Authors:  Antonio Carlos Ribeiro-Filho; Marcus Vinicius Buri; Carlos Castilho Barros; Juliana Luporini Dreyfuss; Helena Bonciani Nader; Giselle Zenker Justo; Rogério Bastos Craveiro; João Bosco Pesquero; Antonio Miranda; Alice Teixeira Ferreira; Edgar Julian Paredes-Gamero
Journal:  BMC Pharmacol Toxicol       Date:  2016-07-07       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.